Literature DB >> 7273449

The ear deformities in mandibulofacial dysostosis (Treacher Collins syndrome).

P D Phelps, D Poswillo, G A Lloyd.   

Abstract

Bilateral conductive deafness is common in mandibulofacial dysostosis with or without atresia of the external auditory meatus. This deafness is due to a wide range of deformities of the ossicular chain associated with a characteristic reduction in the size of the middle ear cavity. The attic and antrum are particularly affected and usually have a slit-like appearance on coronal section tomograms. The inner ear is essentially normal. The tomographic appearances of 44 ears from 22 patients with mandibulofacial dysostosis are described as well as the operative findings in 14. These were correlated with induced ear deformities in an animal model that had features characteristic of human mandibulofacial dysostosis. A review of the findings in the animal model suggests a very close correspondence with the human ear anomalies described at radiological investigation, operation and post-mortem examination. The lesions are largely symmetrical and this, with the characteristic slit attic, helps to differentiate mandibulofacial dysostosis from lesions with different aetiology but similar features such as facial microsomia. The prospects for surgical correction of the deafness in mandibulofacial dysostosis range from very good in mild cases with ossicular discontinuity, to poor where there is severe atresia. The importance of tomograms at an early age is stressed.

Entities:  

Mesh:

Year:  1981        PMID: 7273449     DOI: 10.1111/j.1365-2273.1981.tb01782.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  28 in total

1.  Treacher Collins syndrome with novel ophthalmic findings and visceral anomalies.

Authors:  J L Prenner; G Binenbaum; D F Carpentieri; S M Goldstein; R S Douglas; E Ruchelli; J A Katowitz; R W Hertle
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

Review 2.  Craniofacial birth defects: The role of neural crest cells in the etiology and pathogenesis of Treacher Collins syndrome and the potential for prevention.

Authors:  Paul A Trainor
Journal:  Am J Med Genet A       Date:  2010-08-23       Impact factor: 2.802

3.  The gene for Treacher Collins syndrome maps to the long arm of chromosome 5.

Authors:  M J Dixon; A P Read; D Donnai; A Colley; J Dixon; R Williamson
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

Review 4.  Facial dysostoses: Etiology, pathogenesis and management.

Authors:  Paul A Trainor; Brian T Andrews
Journal:  Am J Med Genet C Semin Med Genet       Date:  2013-10-04       Impact factor: 3.908

5.  Imaging in congenital deafness.

Authors:  R R Phillips; P D Phelps
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

6.  The mutational spectrum in Treacher Collins syndrome reveals a predominance of mutations that create a premature-termination codon.

Authors:  S J Edwards; A J Gladwin; M J Dixon
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

Review 7.  Rare syndromes of the head and face: mandibulofacial and acrofacial dysostoses.

Authors:  Karla Terrazas; Jill Dixon; Paul A Trainor; Michael J Dixon
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2017-02-10       Impact factor: 5.814

Review 8.  Face off against ROS: Tcof1/Treacle safeguards neuroepithelial cells and progenitor neural crest cells from oxidative stress during craniofacial development.

Authors:  Daisuke Sakai; Paul A Trainor
Journal:  Dev Growth Differ       Date:  2016-08-02       Impact factor: 2.053

Review 9.  Syndromic Hearing Loss: A Brief Review of Common Presentations and Genetics.

Authors:  John D Gettelfinger; John P Dahl
Journal:  J Pediatr Genet       Date:  2018-01-04

10.  Prenatal diagnosis in Treacher Collins syndrome using combined linkage analysis and ultrasound imaging.

Authors:  S J Edwards; A Fowlie; M P Cust; D T Liu; I D Young; M J Dixon
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.